Xiaomin Chen
Jinan, 250000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeting YTHDF2 inhibits tumorigenesis of diffuse large B-cell lymphoma through ACER2-mediated ceramide catabolism.
Journal: Journal of advanced research
Published: July 09, 2023
Histone regulator KAT2A acts as a potential biomarker related to tumor microenvironment and prognosis of diffuse large B cell lymphoma.
Journal: BMC cancer
Published: May 26, 2023
Activation of STING by SAMHD1 Deficiency Promotes PANoptosis and Enhances Efficacy of PD-L1 Blockade in Diffuse Large B-cell Lymphoma.
Journal: International journal of biological sciences
Published: April 13, 2023
α-KG inhibits tumor growth of diffuse large B-cell lymphoma by inducing ROS and TP53-mediated ferroptosis.
Journal: Cell death discovery
Published: December 31, 2022
KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway.
Journal: Cellular & molecular biology letters
Published: December 10, 2022
Derivation and validation of a nutrition-covered prognostic scoring system for extranodal NK/T-cell lymphoma.
Journal: Frontiers in nutrition
Published: October 26, 2022
Ferroptosis-related STEAP3 acts as predictor and regulator in diffuse large B cell lymphoma through immune infiltration.
Journal: Clinical and experimental medicine
Published: August 11, 2022
Berberine exerts anti-tumor activity in diffuse large B-cell lymphoma by modulating c-myc/CD47 axis.
Berberine exerts anti-tumor activity in diffuse large B-cell lymphoma by modulating c-myc/CD47 axis.
Journal: Biochemical pharmacology
Published: January 19, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026